Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
honey assume we ad another 25 million shares over the course of the next year
that is counting warrants.
We have 31 million o/s now and then the warrats on top of that. Some will expire.
SO WE ALL BUY. accoriding to all due diligence this market cap it 3times under value where it should be
I hope all can see here that market makers 100% control this stock they can move it in any way they like or that benefits. There is no reasoning when stocks have low volume.
You NEEED TO BU and hold for a FDA approved robot. again. BUY AND hold for FDA. everything before is noise and manipultion
I hope all can see here that market makers 100% control this stock they can move it in any way they like or that benefits. There is no reasoning when stocks have low volume.
You NEEED TO BU and hold for a FDA approved robot. again. BUY AND hold for FDA. everything before is noise and manipultion
pick up those warrants. 2021 is a long time to make profit.
GAP THE SIZE OF SPORTS1 SINGLE PORT HOLE!
HUGEEEEEEEEEEEEE GAP GAPAAPAPAPAPAP.
smart. 2-18 no big gap to make money there. yeh real smart
as you can see it was sold down on games and will turn around on games.
buy and hoold
this stock can gain 100% in one day way waste time. buy and hold
its already signed sealed delivered/ you are missing the boat. buy now and doubel money
i do. a fda approved robot is worth over 1 billion.
you cray aboutn raising 50 million. RAISE the money so what you lose 2$ a share long term
look at the chart. all this is is algorithm trading. end the day flat? why?
this is nothing. and when it moves it will move a 1$ a day. We all have seen that.
remember a dollar in Jan? it jumped to 4$ over nothing. THis is all games. buy and hold
long means hold till FDA. NO point investing otherwise
none unless u flip
HUUUUUUUUUUUUUUGEEEEEEEEEEEEEEE buys coming in. Word on the street must be out on the rebrband
to tell people to give up on a robot that has not even filed for FDA is flat outs HORSE sh*t.
YOu invest for an approved robot not what happens prior.
UNless you are short
raise your hand if you think this is a 60 million robot.
https://titanmedicalinc.com/technology/
playing games. 1500 dollar trade taking is down 5 %
They will not announce this is a fact. so sit back and wait for FDA
I do know that. These suppliers are just that. not partners.
they are suppliers with other business contracts.
need some DD. there is no releease of who it is until after FDA.
INSdiers are not buying because of the insider trading that went on. They are not sure what and what not may not be construed as inside info so there are hands off
We are the market buddy. already invested.
need new blood buyers. thats the only issue
NO BUY SIDE. THE ONLY ISSUE
Quote Information Table
Last Price Today's Change Bid/Size Ask/Size Today's Volume Second Quarter ends 06/30/2019
$2.12 -0.05 (-2.30%) $2.11/4 $2.13/7 33,803 Above Avg
not true.
look at any other robot valuation leading to FDa.
please get your fax. also EVERY analyis agrees this should be at 160 mm market cap.
This is is being sold down as institutions are taking too big a paper loss and are unwinding and then will buy buy back.
they harvest tax where they can and at any time of year.. trust me because I do it and it systematic trading
Nobody will be revealed until after FDA.
This stock needs to weather the storm, it has before. but you need to wait and watch
doesnt matter. Its being met by selling by institutional who are strangle holding it.
any news will be met with large selling for people.
It needs FDA and then stock gains 70 % a day and we bounce.
Hey philly times yours. what are you getting at
They will nor release until approved product. NO reason to expose who they are if the product is not approved because it will hurt that companies current business partners.
come on man. you need to wake up.
Run some numbers for the board. 75 million shares. at 20$. 1.5 billion.
we are at 2$. SCOOOOOOOOOOOOOOOOOOOOOOOOOOOP. that is a 10 bagger
all good reggie. no big deal.
get to FDA
HUGEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEE
UNVEIL THE REBRAND CAT OUT OF THE BAG!
HUIGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGEEEEEEEEEEEEEEEEEEEEE
nobody knows the bottom. YOU 1005 sure do not. that is why you need to average down.1-6 great buys. 50 $ bad buy,
we all have been there.
Make it back claw for it back it will cum
are you here to save me?
Mac isnt sweating are you?
Double Down.
Mack will rebrand and they will offer a raise and then apply for FDA.
The company raised $46 million in an initial public offering in 2000. That same year, the FDA approved use of the da Vinci Surgical System for general laparoscopic surgery, which can be used to address gallbladder disease and gastroesophageal disease. In 2001, the FDA approved use of the system for prostate surgery. The FDA has subsequently approved the system for thoracoscopic surgery, cardiac procedures performed with adjunctive incisions, and gynecologic procedures.[6]
Shortly before going public, Intuitive Surgical was sued for patent infringement by Computer Motion, Inc, its chief rival. Computer Motion had actually gotten into the robotic surgery field earlier than Intuitive Surgical, with its own system, the ZEUS Robotic Surgical System. Although the ZEUS system was approved in Europe, the U.S. Food and Drug Administration had not yet approved it for any procedure at the time that the FDA first approved the da Vinci system. The uncertainty created by the litigation between the companies was a drag on each company's growth. In 2003, Intuitive Surgical and Computer Motion agreed to merge, thus ending the litigation between them.[7] The ZEUS system was ultimately phased out in favor of the da Vinci system.
Before the buyout of Computer Motion, the stock of Intuitive was selling at around $14 per share, adjusted for stock splits. After the merger, the stock price rose significantly (and by 2015 it was at about $500),[8] primarily because of the growth in systems sold (60 in 2002 compared with 431 in 2014) and the number of surgical procedures performed (less than 1,000 in 2002 compared with 540,000 in 2014).